GlassScriptPhysician profile
David F Ray
NPI 1932119989
$904.15
in general payments reported to CMS, 2019-2025
19 companies · $59.25 in 2025
The $59.25 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $287 · 2021: $160 · 2022: $160 · 2023: $75.84 · 2024: $162 · 2025: $59.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $297.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sandoz INC. | $136.66 | 2019 | |
| Grt US Holding, INC. | $85.24 | 2021-2022 | |
| Kerecis Limited | $80.60 | 2022-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Paratek Pharmaceuticals, INC. | $73.48 | 2024 | Nuzyra |
| Orthofix Medical, INC. | $71.58 | 2019-2024 | Physio-Stim |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $53.56 | 2021-2023 | Jublia |
| Horizon Therapeutics Plc | $52.99 | 2021-2022 | |
| Osteomed LLC | $52.99 | 2019-2021 | |
| Depuy Synthes Sales INC. | $51.85 | 2019-2023 | Hammerlock |
| Alfasigma USA, INC. | $37.06 | 2021 | |
| Ibsa Pharma INC. | $31.00 | 2021-2022 | |
| Assertio Therapeutics, INC. | $25.20 | 2019 | |
| Treace Medical Concepts, INC. | $25.07 | 2024 | |
| Merck Sharp & Dohme LLC | $24.89 | 2019 | |
| Organogenesis INC. | $23.91 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $23.05 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $22.48 | 2025 | |
| Averitas Pharma INC. | $16.89 | 2023 | Qutenza |
| Novum Pharma, LLC | $15.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.